Class 2 recall-BD ChloraPrep Clear - 1mL Applicator

Becton Dickinson UK Ltd has informed the MHRA that some units exhibit an open seal on the packaging of the applicator. This defect could increase the risk of the applicator device being contaminated with pathogens, which could lead to increased infection rates for the patients.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-bd-chloraprep-clear-1ml-applicator-becton-dickinson-uk-ltd-el-25-a-slash-22?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=523232d5-0bdd-4537-8674-58051af969ec&utm_content=immediately

MHRA drug alert date: 19/05/25

Further Information

For all medical information enquiries and information on this product, please email safetyinformation@bd.com, or telephone 08000437546.

For stock control enquiries please email info@insightbio.com, or telephone 01707351330.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Company Led Class 2 recall-Mercaptopurine tablets 50mg

Aspen Pharma Trading Limited is recalling a specific batch of Mercaptopurine 50mg tablets as a precautionary measure due to possible microbial contamination.

Drug alert date: 16/05/25

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Various Chemidex products

Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information related to Visual Disturbances.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-chemidex-pharma-ltd-various-products-el-25-a-slash-21?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=e243de6b-1eab-4918-8ada-2250c1d02a06&utm_content=immediately

MHRA drug alert date: 13/05/25

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please email essentialpharmaUK@EU.ProPharmaGroup.com or telephone +44 (0)1423 850700.

For stock control enquiries please email commercial@essentialpharmagroup.com.

class 4 caution in use-Chloramphenicol Eye ointment 1% POM

Blumont Pharma Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of the batch of Chloramphenicol 1% w/w Eye Ointment (POM version only) in the below table.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-chloramphenicol-1-percent-w-slash-w-eye-ointment-blumont-pharma-limited-el-25-a-slash-20?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a7b39a78-d068-448f-a434-38a623f0a06c&utm_content=immediately

MHRA drug alert date: 8/05/25

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please email info@blumontpharma.com, or telephone 01476978568

For stock control enquiries please email manoj@blumontpharma.com, or telephone 01476978568

Class 4 caution in use-Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Capsules

Jubilant Pharmaceuticals BV has informed the MHRA that the outer carton (box) of the product batches mentioned in this notification are missing the medicines legal classification for a Prescription Only Medicine ‘POM’. There is no risk to product quality or safety of the medicines.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-pregabalin-25mg-50mg-75mg-100mg-150mg-200mg-225mg-300mg-capsules-jubilant-pharmaceuticals-nv-el-25-a-slash-19?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=0511c50f-94f9-492c-a7cb-e9451ffcc68f&utm_content=immediately

MHRA drug alert date: 29/04/25

This is a caution in use only we are not accepting stock returns

Further Information

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Class 4 caution in use-PI Brilique 90mg Tablets

G Pharma Ltd have informed the MHRA that there is an error in the spelling of the active ingredient included on the imported carton. The spelling should be ‘Ticagrelor’ but has been printed as ‘Tricagelor’ under the brand name and in the content statement.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-brilique-90mg-tablets-el-25-a-slash-18?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=338050a1-7c68-4c7d-9ebb-14fee1ccad21&utm_content=immediately

MHRA drug alert date: 24/04/25

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries please email ddavies@gpharma.co.uk, or telephone 0161 888 7317. For stock control enquiries please email ddavies@gpharma.co.uk or telephone 0161 888 7317.

Class 2 recall-Lercanidipine HCl 20mg Tablets

We have received a Class 2 Recall from Recordati Industria Chimica e Farmaceutica S.p.A. on Lercanidipine HCl 20mg Tablets.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-lercanidipine-hcl-20mg-tablets-recordati-industria-el-25-a-slash-17?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=070d68eb-f056-4249-95fe-9701644771a1&utm_content=immediately

DMRC Ref: 35334038

Reason: “Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch of Lercanidipine HCl 20mg Tablets. The packs are incorrectly labelled as 10mg on some sides of the product carton when they are 20mg tablets.”

Please can you ensure that your stores quarantine the product listed below.

Further Information

For all medical information enquiries and information on this product, please email medinfo@recordati.co.uk, or telephone +353 (0)87 6245669. For stock control enquiries please email customerservice@recordati.com, or telephone 01491 576 336.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification (17/04/2025), cannot be reimbursed by way of a credit.

May 2025 bank holiday opening hours

To help keep our customers informed of changes to our service, we have published our Early May and Spring 2025 bank holiday opening hours for pharmacy and retail customers.

Early May 2025 bank holiday opening hours

Early May 2025 bank holiday opening hours (for Channel Islands and Isle of Man)

Spring May 2025 bank holiday opening hours

Spring 2025 bank holiday opening hours (for Channel Islands and Isle of Man)

Class 2 recall-Synalar 30g & 60g gel

It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of 2ppm. Reig Jofre UK are recalling the batches as a precautionary measure. This recall is at the pharmacy and wholesaler level.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-synalar-gel-30g-synalar-gel-60g-fluocinoline-acetonide-0-dot-025-percent-reig-jofre-uk-el-25-a-slash-16?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=6cd7db97-6cc0-4a89-b429-009bf1866ec6&utm_content=immediately

MHRA ref:DMRC-35165402

Further Information

For medical information enquiries please contact Reig Jofre UK Medical Information on 0330 1359 434 or by email MedInfoUK@reigjofre.com.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Renacet 465 & 950 mg tablets

RenaCare NephroMed GmbH has informed the MHRA of the presence of an undeclared excipient in the coating of the tablets. This excipient is Macrogol 6000, which has always been included in Renacet Tablets but has been omitted from the list of excipients in error.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-renacet-475-mg-and-950-mg-tablets-calcium-acetate-renacare-nephromed-gmbh-el-25-a15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=23366ae3-59e2-40b3-aa14-5d94fd8c2381&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please telephone 01159 124 253 or email medinfo@stanningleypharma.co.uk

For stock control enquiries telephone 01159 124 253 or email medinfo@stanningleypharma.co.uk